JournalsHub
.online
Find My Journal
JH

Jeffrey R. Harris

Roche (Switzerland) CH

ORCID 0000-0001-8728-7195
371
Publications
12,610
Citations
59
H-Index
168
i10-Index
2.11
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

366 total

Tisotumab vedotin in Japanese patients with recurrent/metastatic cervical cancer: Results from the innovaTV 206 study OA

K. Yonemori, Y. Kuboki, K. Hasegawa, T. Iwata, Hidenori Kato - Cancer Science, 2022
Cited by 25 Semantic Scholar

Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study

Robert L. Coleman, Domenica Lorusso, Christine Gennigens, Antonio González-Martı́n, Leslie M. Randall et al. - The Lancet Oncology, 2021
Cited by 376 OpenAlex

617 Tisotumab vedotin shows immunomodulatory activity through induction of immunogenic cell death

E. Gray, Kelly Hensley, S. Allred, E. Trueblood, J. Gosink - Unknown Venue, 2020
Cited by 2 Semantic Scholar

Abstract 221: Tisotumab vedotin induces anti-tumor activity through MMAE-mediated, Fc-mediated, and Fab-mediated effector functionsin vitro

S. Alley, JeffreyR. Harris, Anthony T. Cao, Elke Gresnigt-van den Heuvel, J. Velayudhan - Experimental and Molecular Therapeutics, 2019
Cited by 14 Semantic Scholar

Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer OA

D. Hong, N. Concin, I. Vergote, J. D. de Bono, B. Slomovitz - Clinical Cancer Research, 2019
Cited by 95 Semantic Scholar

Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition

Jason R. Rock, Christina E. Barkauskas, Michael J. Cronce, Yan Xue, Jeffrey R. Harris et al. - Proceedings of the National Academy of Sciences, 2011
Cited by 1,030 OpenAlex

Intermediate-affinity interleukin-2 receptor expression predicts CD56bright natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis

J. Sheridan, Ying Zhang, K. Riester, M. Tang, L. Efros - Multiple Sclerosis, 2011
Cited by 51 Semantic Scholar

A Pilot Study of Rituximab in Immune-Mediated Inner Ear Disease

S. Cohen, P. Roland, A. Shoup, M. Lowenstein, H. Silverstein - Audiology and Neurotology, 2010
Cited by 45 Semantic Scholar

Reviews of evidence regarding interventions to reduce tobacco use and exposure to environmental tobacco smoke11The names and affiliations of the Task Force members are listed in the front of this supplement and at www.thecommunityguide.org.

David P. Hopkins, Peter A. Briss, Connie J Ricard, Corinne G. Husten, Vilma G Carande-Kulis et al. - American Journal of Preventive Medicine, 2001
Cited by 456 OpenAlex

Priorities among recommended clinical preventive services11The full text of this article is available via AJPM Online at www.elsevier.com/locate/ajpmonline. PDF

Ashley B. Coffield, Michael V. Maciosek, J. Michael McGinnis, Jeffrey R. Harris, M. Blake Caldwell et al. - American Journal of Preventive Medicine, 2001
Cited by 352 OpenAlex

Research Topics

Workplace Health and Well-being (48) School Health and Nursing Education (28) Geological Studies and Exploration (28) Health Policy Implementation Science (24) Geochemistry and Geologic Mapping (23)

Affiliations

Roche (Switzerland)
CH 2025 - 2025
University of Maryland, Baltimore
US 1991 - 1990
Natural Resources Canada
CA 2015 - 1995
Brigham and Women's Hospital
US 2016 - 2016
Washington State Department of Health
US 2024 - 2018

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now